KRAS and familial pancreatic carcinoma: In light of the reduced success of previous attempts to correct genetic alterations in pancreatic cancer through gene therapy, these considerations also highlight the possibility that early intervention against epigenetic changes may be more beneficial for the management of this cancer and likely other malignancies, which are known to associate with Kras mutations.